CAMP4 THERAPEUTICS Correlations
CAMP Stock | USD 4.76 0.39 7.57% |
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
CAMP4 THERAPEUTICS Correlation With Market
Weak diversification
The correlation between CAMP4 THERAPEUTICS PORATION and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CAMP4 THERAPEUTICS PORATION and DJI in the same portfolio, assuming nothing else is changed.
CAMP4 |
Moving against CAMP4 Stock
0.4 | CYCCP | Cyclacel Pharmaceuticals | PairCorr |
0.4 | XOMAO | XOMA | PairCorr |
0.37 | CEROW | CERo Therapeutics | PairCorr |
0.32 | ABPWW | Abpro Holdings Symbol Change | PairCorr |
0.38 | TVGNW | Tevogen Bio Holdings | PairCorr |
0.36 | ACOG | Alpha Cognition Common | PairCorr |
0.34 | ACHL | Achilles Therapeutics PLC | PairCorr |
0.33 | NKGNW | NKGen Biotech, Warrants | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CAMP4 Stock performing well and CAMP4 THERAPEUTICS Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CAMP4 THERAPEUTICS's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DZSI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
HLIT | 1.74 | (0.37) | 0.00 | (0.52) | 0.00 | 3.51 | 18.88 | |||
COMM | 3.45 | 0.19 | 0.04 | 0.11 | 4.38 | 6.70 | 38.42 | |||
NTGR | 2.28 | (0.03) | 0.00 | (0.02) | 0.00 | 4.49 | 12.12 | |||
CMTL | 6.10 | (0.36) | 0.00 | 0.28 | 0.00 | 18.18 | 65.93 | |||
MYNA | 12.78 | (0.91) | 0.00 | (0.55) | 0.00 | 36.96 | 167.72 | |||
KN | 1.18 | (0.31) | 0.00 | (0.30) | 0.00 | 1.86 | 6.22 | |||
ITRN | 1.92 | 0.40 | 0.20 | 0.54 | 1.71 | 4.03 | 21.39 | |||
AVNW | 2.54 | 0.26 | 0.10 | 0.17 | 2.59 | 5.24 | 34.98 | |||
FEIM | 2.19 | (0.14) | 0.00 | (0.08) | 0.00 | 4.39 | 18.93 |
CAMP4 THERAPEUTICS Corporate Management
Kelly Gold | Chief Officer | Profile | |
John Partain | Interim Experience | Profile | |
Erik Schulz | Interim Officer | Profile | |
Christian Horne | Interim Sales | Profile | |
Brett Jackson | Senior Logistics | Profile | |
Mark Gaydos | Chief Officer | Profile |